🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy of a fixed dose of SR58611A(350 mg q12) compared t...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-09
Trial ID
NCT00252356
Treatments Being Tested
The primary objective of the study is to compare, after 8 weeks, the effica...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-01
Trial ID
NCT00432614
Treatments Being Tested
Primary objective is to demonstrate the antidepressant efficacy on the Hami...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2003-09
Trial ID
NCT00825019
Treatments Being Tested
To evaluate the efficacy of two fixed doses of SR58611A (175 mg q12 and 350...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-09
Trial ID
NCT00385307
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of SR58611A...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-03
Trial ID
NCT00332891
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of SR58611A...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-04
Trial ID
NCT00319709
Treatments Being Tested
Primary objective : * To demonstrate the antidepressant efficacy on the Ha...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2003-11
Trial ID
NCT00825058
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of SR58611A...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-12
Trial ID
NCT00266747
Treatments Being Tested
The primary objective of this study is to demonstrate the efficacy of SR586...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00535340
Treatments Being Tested
To evaluate the efficacy of a fixed dose of SR58611A (350mg q12) compared t...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-09
Trial ID
NCT00252343
Treatments Being Tested